skip navigation

Skip Nav

HIV/AIDS Clinical Trials

Clinical Trial Search Results

16 studies were found about Treatment Research, Expanded Access Studies

Compassionate Use of Dolutegravir and Ibalizumab for the Treatment of HIV Infection

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT02028819

HIV-discordant Couple Intrauterine Insemination

Condition: Infertility; HIV Infections

NCT ID: NCT00975546

TMC114-C226: An Early Access Program to Evaluate the Long-term Safety and Tolerability of TMC114 Combined With a Low Dose of Ritonavir (TMC114/r) With Other Antiretrovirals, for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens.

Condition: HIV Infections

NCT ID: NCT00245739

Tipranavir in Patients With Progressive, Systemic HIV-1 Disease Who Have Failed or Are Intolerant to Currently Approved Treatments for HIV Infection

Condition: HIV Infections

NCT ID: NCT00062660

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

Condition: HIV Infections

NCT ID: NCT00097799

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Condition: HIV Infections

NCT ID: NCT00933205

Fosamprenavir Expanded Access

Condition: HIV Infection

NCT ID: NCT00240552

The TMC125-C214 Study Provides Early Access to TMC125 for HIV-1 Infected Patients Who Have Failed Multiple Antiretroviral Regimens and Will Also Gather Information on the Long-term Safety and Tolerability of TMC125 Combined With Other Antiretroviral Drugs.

Condition: HIV-1

NCT ID: NCT00354627

A Treatment Access Program To Provide Maraviroc To Eligible Adult Patients Completing A4001050 Study Until Commercial Availability Of Maraviroc (Celsentri) In India

Condition: Human Immunodeficiency Virus (HIV)

NCT ID: NCT00992654

Atazanavir for HIV Infected Individuals: An Early Access Program

Condition: HIV Infections

NCT ID: NCT00046345

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection

Condition: HIV Infection

NCT ID: NCT00162227

An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: Canada

Condition: HIV Infection

NCT ID: NCT00162188

Early Access of MK0518 in Combination With an Optimized Background Antiretroviral Therapy (0518-023)

Condition: HIV Infections

NCT ID: NCT00377065

Dolutegravir Expanded Access Study

Condition: Infection, Human Immunodeficiency Virus

NCT ID: NCT01536873

A Compassionate Access Protocol For Those Patients Who Have Completed A4001029

Condition: HIV

NCT ID: NCT00801515

Prevention of Transmission of Sexually Transmitted Diseases in the Youth Through Effective Intervention,

Condition: HIV

NCT ID: NCT02069652